Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)

Autor: Monahan, KJ, Bradshaw, N, Dolwani, S, Desouza, B, Dunlop, MG, East, JE, Ilyas, M, Kaur, A, Lalloo, F, Latchford, A, Rutter, MD, Tomlinson, I, Thomas, HJW, Hill, J, Group, Hereditary CRC Guidelines Edelphi Consensus
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Colorectal cancer
Peutz-Jeghers Syndrome
Gastroenterology
DNA Glycosylases
0302 clinical medicine
Risk Factors
Family history
Referral and Consultation
education.field_of_study
medicine.diagnostic_test
Intestinal Polyposis
Adenomatous Polyposis Coli/genetics
Intestinal Polyposis/congenital
Neoplastic Syndromes
Hereditary/genetics

Colonoscopy
Lynch syndrome
Referral and Consultation/standards
3. Good health
Adenomatous Polyposis Coli
Population Surveillance
030220 oncology & carcinogenesis
surveillance
030211 gastroenterology & hepatology
Colorectal Neoplasms
medicine.medical_specialty
Hereditary CRC guidelines eDelphi consensus group
Population
colorectal cancer
genetic testing
03 medical and health sciences
Neoplastic Syndromes
Hereditary

Internal medicine
Colorectal Neoplasms
Hereditary Nonpolyposis/genetics

medicine
Humans
Gastrointestinal cancer
Peutz-Jeghers Syndrome/genetics
education
Life Style
Genetic testing
Family Health
Cancer prevention
Gastroenterology & Hepatology
business.industry
1103 Clinical Sciences
Guideline
DNA Glycosylases/genetics
medicine.disease
Colorectal Neoplasms/genetics
Colorectal Neoplasms
Hereditary Nonpolyposis

inherited cancers
United Kingdom
1114 Paediatrics and Reproductive Medicine
colorectal surgery
business
Ireland
Zdroj: 2019, ' Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) ', Gut, vol. 69, no. 3, pp. 411-444 . https://doi.org/10.1136/gutjnl-2019-319915, https://doi.org/10. 1136/ gutjnl-2019-319915
Monahan, KJ, Bradshaw, N, Dolwani, S, Desouza, B, Dunlop, MG, East, JE, Ilyas, M, Kaur, A, Lalloo, F, Latchford, A, Rutter, MD, Tomlinson, I, Thomas, HJW, Hill, J & group, H CRC G ED C 2019, ' Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). ', Gut . https://doi.org/10.1136/gutjnl-2019-319915
Popis: Heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost 30% of the population in the UK have a family history of CRC. The quantification of an individual’s lifetime risk of gastrointestinal cancer may incorporate clinical and molecular data, and depends on accurate phenotypic assessment and genetic diagnosis. In turn this may facilitate targeted risk-reducing interventions, including endoscopic surveillance, preventative surgery and chemoprophylaxis, which provide opportunities for cancer prevention. This guideline is an update from the 2010 British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland (BSG/ACPGBI) guidelines for colorectal screening and surveillance in moderate and high-risk groups; however, this guideline is concerned specifically with people who have increased lifetime risk of CRC due to hereditary factors, including those with Lynch syndrome, polyposis or a family history of CRC. On this occasion we invited the UK Cancer Genetics Group (UKCGG), a subgroup within the British Society of Genetic Medicine (BSGM), as a partner to BSG and ACPGBI in the multidisciplinary guideline development process. We also invited external review through the Delphi process by members of the public as well as the steering committees of the European Hereditary Tumour Group (EHTG) and the European Society of Gastrointestinal Endoscopy (ESGE). A systematic review of 10 189 publications was undertaken to develop 67 evidence and expert opinion-based recommendations for the management of hereditary CRC risk. Ten research recommendations are also prioritised to inform clinical management of people at hereditary CRC risk.
Databáze: OpenAIRE